Gene Query: SEH1L

Dataset Description Geneva Score
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 55.88
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 42.16
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 42.16
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 36.32
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 30.37
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 29.19
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 29.19
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 27.11
LNCaP treated with iBET 26.89
The landscape of alternative splicing in aggressive prostate cancers 24.91
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 24.82
Developmental stage specific chromosome architecture in human erythroid cells 24.82
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 24.73
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 24.73
hTERT promotes cell adhesion and migration independent of telomerase activity 24.56
Nucleoporin-mediated regulation of cell identity genes 24.28
TCF7L1 knockdown in pancreatic cancer 23.77
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 23.23
Genome wide expression change in LCC2 and MCF-7 cells 22.13
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 21.42
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 20.63
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 20.63
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 20.01
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 19.19
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 18.49
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 17.95
SLAM-seq for K562 endogenous mRNA decay 17.59
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 17.16
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 17.15
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 17.15
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 16.95
A Unique Epigenomic Landscape Defines Human Erythropoiesis 16.95
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 16.52
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 15.96
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 15.85
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 15.76
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 15.75
RNAseq Analysis in glioblastoma cells treated with Mepazine 15.72
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 15.28
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 15.28
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 15.15
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 15.15
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 14.77
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 14.46
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 14.3
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.18
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 14.17
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 14.14
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 13.94
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 13.9
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 13.44
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 13.4
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 13.38
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 13.1
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 13.07
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 12.37
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.35
Fbxo32 mediated gene expression program underlies EMT and metastasis 12.33
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 12.29
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 12.25
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 12.25
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.24
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.24
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.0
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.97
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 11.91
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 11.88
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 11.87
An RNA-centric dissection of host complexes controlling flavivirus infection 11.87
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.83
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.83
Functional role of SLIT2 and ROBO1 in trophoblasts 11.67
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 11.66
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.64
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 11.62
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 11.58
Trans-differentiation of human adult peripheral blood T cells into neurons 11.46
Integrin signaling regulates YAP/TAZ to control skin homeostasis 11.41
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 11.36
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 11.36
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 11.36
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.34
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 11.12
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.12
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 11.1
Hijacking of stress response machinery by oncogenes in acute leukaemia 11.01
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 11.01
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.95
Depicting early human development and germ cell origin with porcine embryos 10.95
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 10.88
RNA sequencing of primary human platelets and in vitro cell lines 10.71
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.7
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 10.65
Co-transcriptional loading of RNA export factors shapes the human transcriptome 10.43
RNAseq of HEK293 cells after Chtop knockdown 10.43
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 10.38
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 10.38
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 10.33
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.33
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.31
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 10.22
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 10.2
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 10.15
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.08
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.08
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 10.05
Primary human trophoblast from term placenta 10.04
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 10.04
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 9.98
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 9.89
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 9.87
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.85
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 9.82
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 9.74
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 9.73
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 9.69
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.62
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.6
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 9.58
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 9.48
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.48
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 9.47
Regulation of protein translation during mitosis 9.44
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 9.44
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 9.44
RNA-seq analysis of differentiating human erythroblasts 9.4
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 9.36
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.31
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 9.2
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 9.18
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 9.14
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.14
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.13
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.13
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.08
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.08
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 9.07
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 9.05
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 9.04
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 9.01
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 8.99
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 8.97
Dtx3L and Androgen Signaling in Prostate Cancer 8.92
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.88
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.78
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.78
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 8.78
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.77
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 8.73
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.72
Identification of global regulators of T-helper cell lineage specification 8.72
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.71
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.71
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.65
MYC dependent mRNA translation shapes gene expression and cell biology 8.64
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.55
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 8.55
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 8.54
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.53
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.53
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 8.48
Co-regulation of splicing by Rbfox1 and hnRNP M 8.39
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 8.39
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 8.31
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 8.29
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.28
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 8.28
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 8.22
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 8.17
FBXW7 modulates stress response by post-translational modification of HSF1 8.16
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.16
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.15
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 8.14
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 8.14
RNA-Seq with and without RNase treatment in PCa cell lines 8.12
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 8.1
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 8.1
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 8.02
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.95
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 7.94
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 7.94
hnRNP C is a key regulator of protein synthesis in mitosis 7.94
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.9
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 7.89
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 7.88
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 7.86
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 7.86
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 7.85
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.81
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.81
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.78
RIG-I and MDA5 fRIP during KSHV lytic reactivation 7.76
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.76
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.76
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 7.76
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 7.75
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.73
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 7.67
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.67
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 7.66
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.66
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.66
MYCi975 regulates MYC target genes 7.64
Effect of mitochondria deficiency on senescence-associated gene expression 7.61
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.61
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.61
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 7.61
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.6
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.6
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.6
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 7.58
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.57
Zone dependent distinctive gene expression profile of the normal human liver tissue 7.56
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.52
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.49
Genome wide expression change by RNF168 knocking down in MCF-7 cells 7.47
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.45
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.43
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.39
Total RNA-seq in ALL-SIL upon JQ1 inhibition 7.39
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 7.38
Transcription control by the ENL YEATS domain in acute leukemia 7.38
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.37
Uridylation by TUT4 and TUT7 marks mRNA for degradation 7.36
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 7.36
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 7.35
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 7.35
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 7.34
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.32
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.3
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.2
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 7.11
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.11
Human HAP1 cells before and after nutrient deprivation 7.11
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 7.11
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.1
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 7.1
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.07
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 7.07
Gene expression profile in breast cancer cells 7.06
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 7.06
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.04
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 7.03
FOXD3 is a novel tumor suppressor in lung cancer 7.0
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.0
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 7.0
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.99
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.99
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.98
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.94
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.93
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.93
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 6.93
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.92
Identification of HOXB13 target genes responsive to BET inhibitors 6.92
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.9
Transcriptome-wide response to synthetic chromatin protein PcTF 6.9
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.88
Primary Human B-cell Temporal Response to CD40L Stimulation 6.87
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.85
Silencing SPIB in attached and floating state of H1703 lung cancer cells 6.85
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.85
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.85
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 6.84
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 6.84
Triple vectors expand AAV transfer capacity in the retina 6.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.83
BASP1 modifies the Tamoxifen response 6.83
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 6.82
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.81
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.81
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.8
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 6.78
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 6.76
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 6.65
MeRIP-seq for heat shock in B-cell lymphoma cells 6.6
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.6
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 6.59
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.56
RNA-sequencing of human tendon after injury 6.49
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.45
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.44
WRN knockout effects upon gene expression in SW48 and OVK18 6.34
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.32
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.31
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.31
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.3
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.3
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 6.28
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.27
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.27
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 6.22
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 6.21
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.2
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.2
Identification of Sin3B regulated genes during quiescence 6.16
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.15
Fusion discovery in breast cancer cell line 6.15
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.13
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 6.09
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 6.04
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.03
Effect of PRDM11 depletion in U2932 cells 6.02
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.96
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.95
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.95
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.93
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.91
The Genetic Landscape of Diamond-Blackfan Anemia 5.89
HBEC-shp53-PCHD7 5.83
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.8
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 5.74
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 5.74
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.71
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.71
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.66
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.66
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.62
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.58
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.55
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 5.53
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 5.53
Genome-wide discovery of human splicing branchpoints [RNAse] 5.48
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 5.46
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 5.46
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 5.46
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.41
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.4
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.38
RNA-seq of RKO cells with cTAZ KO or putback 5.33
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 5.33
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 5.33
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 5.3
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 5.3
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 5.29
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 5.29
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.28
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.26
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 5.25
O-glcnAc reprograms cellular energetics 5.25
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 5.24
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.16
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 5.09
Transcriptome of activated human and mouse MAIT cells 4.95
A map of gene expression in neutrophil-like cell lines 4.94
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.87
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.85
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.83
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.8
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.77
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.77
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.72
Gene expression in GBM with Cav3.2 inhibition 4.72
CDK12 mediated transcriptional regulation in U2OS cells 4.65
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.65
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.6
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.6
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.59
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.59
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.57
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.54
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 4.54
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.47
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 4.45
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 4.42
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.38
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.34
Recovery and analysis of nascent RNA 4.31
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 4.31
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.21
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.2
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 4.19
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.16
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.1
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.09
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.07
Capturing the Interactome of Newly Transcribed RNA 4.07
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.04
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.02
6mer seed toxicity in tumour suppressive microRNAs 4.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 4.0
RNA sequencing with KSHV infection and enrichment for circular RNAs 3.98
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.96
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.85
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.83
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.77
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.71
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.6
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.57
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.57
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.56
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 3.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 3.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.46
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.45
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.44
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 3.42
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.39
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.38
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.34
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.33
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.28
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.28
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.18
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.16
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.08
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.06
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.03
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.03
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.01
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.88
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.72
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.6
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.59
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.59
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.52
Noncoding regions are the main source of targetable tumor-specific antigens 2.45
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.43
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.43
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.35
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.2
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.19
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.18
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.18
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.18
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.05
RNA seq with AML (NB4) cells upon FTO inhibition 2.03
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.99
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.97
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.97
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.97
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.94
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.94
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.93
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.9
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.9
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.89
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.88
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.88
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.88
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.84
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.79
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.77
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.77
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.74
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.69
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.67
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 1.66
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 1.66
Mitochondrial dsRNA triggers antiviral signalling in humans 1.6
Myc activation coordinates gene transcription and protein translation responses 1.58
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.48
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.43
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.26
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.25
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.25
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.15
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.15
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.1
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.97
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.94
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.94
N6-methyladenine DNA Modification in Glioblastoma 0.94
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.94
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.84
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.8
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.75
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.68
Impact on erythroid progenitor type on erythroid differntiation 0.61
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.48
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.47
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.45
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.45
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.45
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.39
Transcriptome-wide modulation of splicing by the exon junction complex 0.36
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.34
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.33
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.32
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.32
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.29
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.27
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.26
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.25
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.24
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.21
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.18
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.17
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.15
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.07
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation